(Q34216430)

31 July 2017

title

Detection and characterization of subvisible aggregates of monoclonal IgG in serum (English)

1 reference

31 July 2017

5

Wim Jiskoot

1 reference

31 July 2017

Vasco Filipe

1

1 reference

31 July 2017

Robert Poole

series ordinal

2

1 reference

31 July 2017

Olubukayo Oladunjoye

series ordinal

3

1 reference

31 July 2017

Kevin Braeckmans

series ordinal

4

1 reference

31 July 2017

publication date

31 March 2012

1 reference

31 July 2017

published in

Pharmaceutical Research

1 reference

31 July 2017

volume

29

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

2202-2212

1 reference

Taylor dispersion analysis compared to dynamic light scattering for the size analysis of therapeutic peptides and proteins and their aggregates

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Effects of surfaces and leachables on the stability of biopharmaceuticals

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Chemical modifications in therapeutic protein aggregates generated under different stress conditions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Genetically designed Peptide-based molecular materials.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Fluorescence single particle tracking for the characterization of submicron protein aggregates in biological fluids and complex formulations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Strategies for the assessment of protein aggregates in pharmaceutical biotech product development

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Identification and localization of unpaired cysteine residues in monoclonal antibodies by fluorescence labeling and mass spectrometry

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

A therapeutic antibody and its antigen form different complexes in serum than in phosphate-buffered saline: a study by analytical ultracentrifugation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Immunological risk of injectable drug delivery systems

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Protein aggregation: pathways, induction factors and analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Is any measurement method optimal for all aggregate sizes and types?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Effects of protein aggregates: an immunologic perspective

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Structure-immunogenicity relationships of therapeutic proteins

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Bioequivalence and the immunogenicity of biopharmaceuticals

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

The reaction of monomeric and aggregated immunoglobulins with C1.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

The subunit composition and sedimentation properties of human C1

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Molecular determinants of immunogenicity: the immunon model of immune response

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3399096

Protein aggregation and bioprocessing

28 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

Sizing nanomatter in biological fluids by fluorescence single particle tracking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

Micro-mirrors for nanoscale three-dimensional microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

A critical review of methods for size characterization of non-particulate protein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

Protein aggregation--pathways and influencing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-012-0749-X

Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway

21 January 2018

1 reference

12 December 2020

The effects of radioiodination and fluorescent labelling on albumin

1 reference

12 December 2020

Kinetics of peroxynitrite reaction with amino acids and human serum albumin

1 reference

12 December 2020

Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study

1 reference

12 December 2020

Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress

1 reference

12 December 2020

How Gold Nanoparticles Have Stayed in the Light: The 3Mʼs Principle

1 reference

12 December 2020

Vaccines as physically and chemically well-defined pharmaceutical dosage forms

1 reference

12 December 2020

10.1007/S11095-012-0749-X

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference